Purchase Order HHSF223201510096P

<p>This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Bioproximity LLC, a for-profit limited liability company, for global proteomic profiling sample preparation and data services. The contract has a ceiling value of $89,100.00 and an ultimate completion date of August 2, 2016. This contract award is not associated with a larger vehicle and does not have a set-aside designation.</p>

<p>This is a firm fixed-price purchase order awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Sequoia Research Products LTD, a foreign-owned for-profit organization, for a study on drug repositioning. The contract has a ceiling value of $124,852.00 and an ultimate completion date of October 17, 2015. The contract is not set aside for any specific type of business. No further details about a larger contract vehicle are provided.</p>

<p>This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Pharsight Corporation, a small business contractor. The contract has a ceiling value of $148,999.29 and a completion date of July 14, 2016. The contract was set aside for total small business participation. The place of performance is St. Louis, MO. No additional details about the specific products or services being delivered under this contract were provided.</p>

<p>This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency, to Asischem Inc. for the custom synthesis of Compound 8 for Robert Cragie, Building 5 Room 439. The contract has a ceiling value of $14,997.00 and was awarded on September 28, 2007, with an ultimate completion date of October 14, 2007. The contract does not have a set-aside designation.</p>

This is a $81,460 firm fixed price purchase order awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Pepscan Presto B.V., a foreign-owned for-profit company. The contract is for the acquisition, characterization, and optimization of constrained peptides targeting glypican, in support of the NCI's Molecular Imaging Program. The work will involve creating peptide libraries,...

<p>This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration, a civilian federal agency, to GEA Systems North America LLC, a for-profit organization, for plant pharmaceutical manufacturing services. The contract has a ceiling value of $77,000.00 and a completion date of May 31, 2021. It is not associated with a set-aside program. No additional information about subcontractors or the agency's programs is provided.</p>

This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 to CPC Scientific Inc., a for-profit manufacturer of goods, for the synthesis of peptides in support of research. The contract has a potential value of $28,852.00 and a completion date of April 18, 2025. There is no set-aside designation mentioned. Without additional information about the original solicitation, the specific products or...

This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 1 (VISN 1) to Chemscene LLC, a minority-owned, Asian-Pacific American for-profit business, for peptide syntheses. The contract has a ceiling value of $42,750.00 and a performance period ending on May 27, 2026. The contract does not have a set-aside designation. Additional details about the specific products or services requested are not provided in the information given.

This $227,480 firm fixed price purchase order was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Clarivate Analytics (Us) LLC, a global provider of scientific research databases and analytics platforms. The contract is for data acquisition services related to active pharmaceutical ingredient (API) manufacturing, with a completion date of September 24, 2023. Clarivate Analytics, a foreign-owned for-profit company, has held multiple indefinite...

This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development, a civilian federal agency, to Xerimis Inc., a for-profit Subchapter S Corporation. The contract has a ceiling value of $18,586.19 and was awarded on February 11, 2019, with a period of performance ending on February 10, 2020. The contract does not have a set-aside designation. The contract was awarded directly to the prime contractor, Xerimis Inc., and there is no...